Effect of BCG on delayed hypersensitivity responses of patients with neoplastic disease.
D000818:Animals; D000937:Antigen-Antibody Reactions / Q000187:drug effects; D001500:BCG Vaccine / Q000494:pharmacology / Q000627:therapeutic use*; D002417:Cattle / Q000276:immunology; D002699:Chlorambucil / Q000494:pharmacology / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000494:pharmacology / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000276:immunology / Q000628:therapy*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000628:therapy*; D007106:Immune Sera; D007945:Leukemia, Lymphoid / Q000276:immunology / Q000628:therapy*; D007951:Leukemia, Myeloid / Q000276:immunology / Q000628:therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000276:immunology / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology / Q000628:therapy*; D012882:Skin Tests; D013268:Stimulation, Chemical; D013997:Time Factors; D014373:Tuberculin / Q000494:pharmacology
D001500:BCG Vaccine; D007106:Immune Sera; D014373:Tuberculin; D002699:Chlorambucil; D003520:Cyclophosphamide